Sort   by:  
 Page size 
TranscriptomicsClinical acute lymphoblastic leukemia samples (untreated) with known asparaginase LC50 values
Samples of pediatric acute lymphoblastic leukemia obtained from patients at diagnosis. All samples contain at least 77% blasts. Asparaginase LC50 values were determined for each of these samples. (LC50 was determined on a different aliquot of the same sample.) Set of arrays organized by shared bio...
ORGANISM(S): Homo sapiens 
2006-01-20 | E-GEOD-4070 | biostudies-arrayexpress
TranscriptomicsALL Translocations
Cell lines and pediatric acute lymphoblastic leukemia samples with either BCR/ABL, TEL/AML1 or MLL abnormalities Set of arrays organized by shared biological context, such as organism, tumors types, processes, etc. Using regression correlation
ORGANISM(S): Homo sapiens 
2005-12-20 | E-GEOD-3884 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of clinical pediatric acute lymphoblastic leukemia ALL samples after in vitro exposure to Lasp (and matched controls)
Samples of pediatric acute lymphoblastic leukemia. All samples contain at least 90% blasts. Each sample was split into two flasks, one of which was exposed to 2IU/ml of L-asparaginase. The other flask served as a control. Cells were lysed at the times indicated.
ORGANISM(S): Homo sapiens 
2005-11-11 | E-SMDB-2821 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of time series of in vitro 2 IU/ml L-asparaginase exposure in acute lymphoblastic leukemia cell lines
Time series of in vitro 2 IU/ml L-asparaginase exposure in acute lymphoblastic leukemia cell lines.
ORGANISM(S): Homo sapiens 
2005-11-11 | E-SMDB-2978 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human clinical pediatric acute lymphoblastic leukemia (ALL) obtained from patients at diagnosis, human pretreatment, at least 70% blasts
Samples of pediatric acute lymphoblastic leukemia obtained from patients at diagnosis. All samples contain at least 77% blasts. Asparaginase LC50 values were determined for each of these samples. (LC50 was determined on a different aliquot of the same sample.)
ORGANISM(S): Homo sapiens 
2005-11-11 | E-SMDB-2820 | biostudies-arrayexpress
UnknownFine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease.
Not available
S-EPMC3036586 | biostudies-literature
UnknownEffects of medical therapies on retinopathy progression in type 2 diabetes.
Not available
S-EPMC4026164 | biostudies-literature
UnknownEffect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Not available
S-EPMC4123233 | biostudies-literature
UnknownEffects of combination lipid therapy in type 2 diabetes mellitus.
Not available
S-EPMC2879499 | biostudies-literature
UnknownEffects of intensive blood-pressure control in type 2 diabetes mellitus.
Not available
S-EPMC4123215 | biostudies-literature
Sort   by:  
 Page size